Transcatheter aortic valve replacement is cost effective compared with surgical replacement for low-risk patients

An economic analysis of data from PARTNER 3, a randomized trial comparing transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in patients with severe aortic stenosis and low surgical risk, found that despite higher procedural costs, at 2-year follow-up, quality-adjusted life expectancy was greater and total costs were lower with TAVR; as […]

Scientists take the study of regeneration to the next level by making three-banded panther worms transgenic

Three-banded panther worms are an incredibly impressive marine animal. Known scientifically as the acoel worm named Hofstenia miamia, these tiny animals that grow to only 500 micrometers can perform one of the greatest feats in the animal world, whole-body regeneration. Remove Hofstenia miamia’s tail and it will grow another. Remove its head and another one, […]

Patient economic burden for cancer care $21.1 billon in 2019

Patient economic burden associated with cancer care was projected to be $21.1 billion in 2019, according to a report published online Oct. 26 in the Journal of the National Cancer Institute. Y. Robin Yabroff, Ph.D., from the American Cancer Society in Kennesaw, Georgia, and colleagues quantified patient economic burden, including out-of-pocket and patient-time costs, associated […]

It’s time to replace your smoke alarm batteries

Setting your clocks back an hour this Sunday also means it’s time to replace the batteries in your smoke detectors and carbon monoxide alarms, the U.S. Consumer Product Safety Commission (CPSC) says. Working alarms are especially important because people are spending more time at home due to the pandemic, which means furnaces, fireplaces and other […]

Durvalumab immunotherapy with standard chemotherapy improved survival in malignant pleural mesothelioma

The PrE0505 phase 2 clinical trial results are published in the November 8 issue of Nature Medicine. The study evaluated the addition of durvalumab immunotherapy to standard chemotherapy in patients with previously untreated, inoperable malignant pleural mesothelioma (MPM), a cancer of the tissues that line the lungs. The trial met its primary endpoint with a […]